Table 4. AD exacerbation during ICI therapy.
Characteristic | Patients (n) |
---|---|
Flare of underlying AD | |
1. Patients who did not develop AD flare | 30 |
2. Patients who developed AD flare | 12 |
Grades of AD flares | |
1. Grade 1–2 | 7 |
2. Grade 3–4 | 3 |
3. Grade unknown | 2 |
Treatment required for AD flares | |
1. No treatment required/supportive care | 1 |
2. Corticosteroids only | 8 |
3. Tofacitinib | 1 |
4. Infliximab | 1 |
5. Plasmapheresis | 1 |
ICI therapy during/after AD flare | |
• Continued | 7 |
• Permanently discontinued | 5 |
AD, autoimmune disease; ICI, Immune check point inhibitor.